https://www.atryshealth.com/es/articulo/ 2022-03-07T11:25:34+00:00 https://www.atryshealth.com/es/articulo/patente-2-medium-length-headline/ 2021-09-13T09:26:14+00:00 https://www.atryshealth.com/es/articulo/articulo-6-medium-length-headline/ 2021-09-13T10:24:09+00:00 https://www.atryshealth.com/es/articulo/articulo-6-medium-length-headline/ 2021-09-21T07:50:55+00:00 https://www.atryshealth.com/es/articulo/myc-protein-expression-and-genetic-alterations-have-prognostic-impact-in-patients-with-diffuse-large-b-cell-lymphoma-treated-with-immunochemotherapy/ 2021-09-21T07:53:47+00:00 https://www.atryshealth.com/es/articulo/myc-protein-expression-and-genetic-alterations-have-prognostic-impact-in-patients-with-diffuse-large-b-cell-lymphoma-treated-with-immunochemotherapy/ 2021-09-21T07:53:57+00:00 https://www.atryshealth.com/es/articulo/efficacy-of-erlotinib-in-patients-with-relapsed-gliobastoma-multiforme-who-expressed-egfrviii-and-pten-determined-by-immunohistochemistry/ 2021-09-21T07:57:30+00:00 https://www.atryshealth.com/es/articulo/efficacy-of-erlotinib-in-patients-with-relapsed-gliobastoma-multiforme-who-expressed-egfrviii-and-pten-determined-by-immunohistochemistry/ 2021-09-21T07:57:56+00:00 https://www.atryshealth.com/es/articulo/epithelial-to-mesenchymal-transition-mediates-docetaxel-resistance-and-high-risk-of-relapse-in-prostate-cancer/ 2021-09-21T08:00:57+00:00 https://www.atryshealth.com/es/articulo/epithelial-to-mesenchymal-transition-mediates-docetaxel-resistance-and-high-risk-of-relapse-in-prostate-cancer/ 2021-09-21T08:01:01+00:00 https://www.atryshealth.com/es/articulo/granzyme-a-contributes-to-inflammatory-arthritis-in-mice-through-stimulation-of-osteoclastogenesis/ 2021-09-21T08:34:35+00:00 https://www.atryshealth.com/es/articulo/granzyme-a-contributes-to-inflammatory-arthritis-in-mice-through-stimulation-of-osteoclastogenesis/ 2021-09-21T08:34:43+00:00 https://www.atryshealth.com/es/articulo/molecular-profiling-of-peripheral-blood-is-associated-with-circulating-tumor-cells-content-and-poor-survival-in-metastatic-castration-resistant-prostate-cancer/ 2021-09-21T08:42:57+00:00 https://www.atryshealth.com/es/articulo/molecular-profiling-of-peripheral-blood-is-associated-with-circulating-tumor-cells-content-and-poor-survival-in-metastatic-castration-resistant-prostate-cancer/ 2021-09-21T08:43:08+00:00 https://www.atryshealth.com/es/articulo/imageo-integrative-gene-expression-meta-analysis-from-geo-database/ 2021-09-21T08:44:24+00:00 https://www.atryshealth.com/es/articulo/imageo-integrative-gene-expression-meta-analysis-from-geo-database/ 2021-09-21T08:44:29+00:00 https://www.atryshealth.com/es/articulo/molecular-profiling-of-peripheral-blood-is-associated-with-circulating-tumor-cells-content-and-poor-survival-in-metastatic-castration-resistant-prostate-cancer-2/ 2021-09-21T08:45:37+00:00 https://www.atryshealth.com/es/articulo/molecular-profiling-of-peripheral-blood-is-associated-with-circulating-tumor-cells-content-and-poor-survival-in-metastatic-castration-resistant-prostate-cancer-2/ 2021-09-21T08:47:34+00:00 https://www.atryshealth.com/es/articulo/polyethylene-glycol-improves-current-methods-for-circulating-extracellular-vesicle-derived-dna-isolation/ 2021-09-21T08:48:52+00:00 https://www.atryshealth.com/es/articulo/polyethylene-glycol-improves-current-methods-for-circulating-extracellular-vesicle-derived-dna-isolation/ 2021-09-21T08:48:58+00:00 https://www.atryshealth.com/es/articulo/patente-2-medium-length-headline/ 2021-09-21T08:52:02+00:00 https://www.atryshealth.com/es/articulo/egfr-and-pten-gene-alterations-predicts-survival-in-patients-with-brain-tumors/ 2021-09-21T08:54:33+00:00 https://www.atryshealth.com/es/articulo/egfr-and-pten-gene-alterations-predicts-survival-in-patients-with-brain-tumors/ 2021-09-21T08:54:37+00:00 https://www.atryshealth.com/es/articulo/methods-for-prognosis-of-diffuse-large-b-cell-lymphoma/ 2021-09-21T08:56:52+00:00 https://www.atryshealth.com/es/articulo/methods-for-prognosis-of-diffuse-large-b-cell-lymphoma/ 2021-09-21T09:15:57+00:00 https://www.atryshealth.com/es/articulo/methods-for-prognosis-of-diffuse-large-b-cell-lymphoma/ 2022-03-07T11:14:43+00:00 https://www.atryshealth.com/es/articulo/egfr-and-pten-gene-alterations-predicts-survival-in-patients-with-brain-tumors/ 2022-03-07T11:16:26+00:00 https://www.atryshealth.com/es/articulo/polyethylene-glycol-improves-current-methods-for-circulating-extracellular-vesicle-derived-dna-isolation/ 2022-03-07T11:17:23+00:00 https://www.atryshealth.com/es/articulo/patente-2-medium-length-headline/ 2022-03-07T11:19:29+00:00 https://www.atryshealth.com/es/articulo/molecular-profiling-of-peripheral-blood-is-associated-with-circulating-tumor-cells-content-and-poor-survival-in-metastatic-castration-resistant-prostate-cancer-2/ 2022-03-07T11:20:19+00:00 https://www.atryshealth.com/es/articulo/imageo-integrative-gene-expression-meta-analysis-from-geo-database/ 2022-03-07T11:21:07+00:00 https://www.atryshealth.com/es/articulo/molecular-profiling-of-peripheral-blood-is-associated-with-circulating-tumor-cells-content-and-poor-survival-in-metastatic-castration-resistant-prostate-cancer/ 2022-03-07T11:21:53+00:00 https://www.atryshealth.com/es/articulo/granzyme-a-contributes-to-inflammatory-arthritis-in-mice-through-stimulation-of-osteoclastogenesis/ 2022-03-07T11:22:53+00:00 https://www.atryshealth.com/es/articulo/epithelial-to-mesenchymal-transition-mediates-docetaxel-resistance-and-high-risk-of-relapse-in-prostate-cancer/ 2022-03-07T11:23:40+00:00 https://www.atryshealth.com/es/articulo/efficacy-of-erlotinib-in-patients-with-relapsed-gliobastoma-multiforme-who-expressed-egfrviii-and-pten-determined-by-immunohistochemistry/ 2022-03-07T11:24:22+00:00 https://www.atryshealth.com/es/articulo/myc-protein-expression-and-genetic-alterations-have-prognostic-impact-in-patients-with-diffuse-large-b-cell-lymphoma-treated-with-immunochemotherapy/ 2022-03-07T11:25:03+00:00 https://www.atryshealth.com/es/articulo/articulo-6-medium-length-headline/ 2022-03-07T11:25:34+00:00